82 %The negative predictive value of malaria rapid diagnostic tests (mRDTs) was 82%, far greater than microscopy at 39%.
Nigeriapaludismepublished 2024The American journal of tropical medicine and hygienePubMeddocument of 6 observations
Gold tier: mechanically validated evidence, with its primary source.
8,823 evidence items · page 121 / 353
82 %The negative predictive value of malaria rapid diagnostic tests (mRDTs) was 82%, far greater than microscopy at 39%.
Nigeriapaludismepublished 2024The American journal of tropical medicine and hygienePubMeddocument of 6 observations
5.3 %Cryptococcosis accounted for 5.3% (n = 6) of the 114 reported IFI cases in the Nigerian paediatric population.
Nigeriacryptococcosisobserved 1964–2023published 2025Journal de mycologie medicalePubMeddocument of 17 observations
90.3 %Oral candidiasis accounted for 1,473 (90.3%) of the 1,632 opportunistic fungal infection episodes among HIV-infected patients assessed at the PEPFAR outpatient clinic at Lagos University Teaching Hospital between April 2004 and February 2016.
Nigeriaoral candidiasisobserved April 2004-February 2016published 2020African health sciencesPubMeddocument of 12 observations
1.847 AORMale infants were associated with increased odds of macrosomia compared to female infants (adjusted odds ratio = 1.847, 95% CI: 1.016–3.357).
Nigeriamacrosomiapublished 2025BMC pediatricsPubMeddocument of 8 observations
1.73 %The overall hepatitis C positivity rate in Nigeria was 1.73%.
Nigeriahépatite Cobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations
68.7 %In the study, 68.7% of the type 2 diabetic out-patients had over-nutrition.
Nigeriadiabète de type 2published 2019Diabetes & metabolic syndromePubMeddocument of 16 observations
42 yearsThe mean age of patients with type II diabetes mellitus was 42 ± 11.94 years.
Nigeriatype II diabetes mellituspublished 2023West African journal of medicinePubMeddocument of 8 observations
1.4 %Among Plasmodium falciparum isolates from Lagos, Nigeria, the pfcrt haplotype CVMDT was detected in 1.4%.
Nigeriapaludismepublished 2026Biochemical geneticsPubMeddocument of 16 observations
13.5 %Dengue monoinfection occurred in 27 (13.5%) of the 200 febrile patients.
Nigeriadenguepublished 2025Scientific reportsPubMeddocument of 13 observations
1.2 mumol/litre of blood-medium mixtureThe 99% inhibitory concentration of quinine against Plasmodium falciparum isolates was 1.20 mumol/litre of blood-medium mixture.
Nigeriapaludismepublished 1990Transactions of the Royal Society of Tropical Medicine and HygieneOpenAlexdocument of 22 observations
7 genomesSequencing of African swine fever virus (ASFV) generated 7 genomes characterized as genotype II.
NigeriaAfrican swine fever virus (ASFV)published 2025Pathogens (Basel, Switzerland)europe_pmcdocument of 5 observations
16.67 %Among mothers aged ≥41 years, the malaria prevalence was 16.67%.
Nigeriapaludismepublished 2023Journal of vector borne diseasesPubMeddocument of 8 observations
78 %Among Test and Treat patients with a documented viral load, 78% were suppressed (≤400 copies/ml) at 12 months.
NigeriaVIH/sidapublished 2019PloS onePubMeddocument of 7 observations
198 casesAmong 301 obese individuals aged 20 years and above in two urban settlements within Enugu metropolis, 198 had hypertension.
Nigeriahypertension artériellepublished 2020Nigerian journal of clinical practicePubMeddocument of 3 observations
95.8 %Sentinel lymph node biopsy with methylene blue dye achieved an accuracy of 95.8%.
Nigeriaclinical axillary node-negative breast cancerpublished 2022Nigerian journal of clinical practicePubMeddocument of 8 observations
65.2 %Positive predictive value of CareStart™ for malaria diagnosis was 65.2%.
Nigeriapaludismepublished 2016Malaria research and treatmenteurope_pmcdocument of 14 observations
35.2 yearsThe mean age of patients with AIDS-related Kaposi's sarcoma was 35.2 ± 6.5 years.
NigeriaAIDS-related Kaposi's sarcomapublished 2022West African journal of medicinePubMeddocument of 10 observations
34.6 %The K76T mutation associated with chloroquine and amodiaquine resistance had a moderate prevalence of 34.6% in the studied clinical isolates from Nigeria.
Nigeriapaludismepublished 2019Malaria journaleurope_pmcdocument of 2 observations
13,676 casesCervical cancer accounted for 13,676 new cases in Nigeria in 2022.
Nigeriacancer du col de l'utérusobserved 2022published 2026Rural and remote healthPubMeddocument of 21 observations
98 %The cure rate was 98% with artemether on day 14.
Nigeriapaludismeobserved day 14published 1996Annals of tropical paediatricseurope_pmcdocument of 6 observations
98.1 %Microscopically verified cancers accounted for 98.1% of reported cancers in Egor, Oredo, and Uhunmwonde LGAs of Edo state, Nigeria, from 2016 to 2018.
Nigeriacancer (non précisé)observed 2016 to 2018published 2024BMC public healthPubMeddocument of 8 observations
11.15 allelesAllelic richness was 11.15.
Nigeriapaludismepublished 2021Malaria JournalOpenAlexdocument of 4 observationsDOI 10.1186/s12936-021-03734-x
87.3 %Fully automated digital microscopy showed a sensitivity of 87.3% (95% CI: 81.3–92.0) for detection of Schistosoma haematobium eggs in urine, using conventional microscopy as reference.
Nigeriaschistosomiasepublished 2022The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observationsDOI 10.4269/ajtmh.22-0276
18 casesCoronary artery disease (CAD) was confirmed in 18 out of 46 patients referred for coronary angiography in Ado-Ekiti, Nigeria, from August 2019 to December 2020.
Nigeriacoronary artery disease (CAD)observed August 2019 to December 2020published 2025The Pan African medical journalPubMeddocument of 7 observations
90 %The self-reported ART adherence level was 90.0% in the north-east of Nigeria.
NigeriaVIH/sidapublished 2022African journal of AIDS research : AJARPubMeddocument of 4 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.